Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-05-01FDA Approved: AZITHROMYCIN DIHYDRATE — Supplemental Application (Precision Dose, Inc.)
FDA approved a supplemental application for azithromycin dihydrate submitted by Precision Dose, Inc.
-
FDA approval · 2020-04-22FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)
FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.
-
FDA approval · 2020-03-09FDA Approved: CEFDINIR — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for CEFDINIR (cefdinir) from Aurobindo Pharma Limited, a generic cephalosporin antibiotic.
-
FDA approval · 2020-02-11FDA Approved: CEFDINIR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for CEFDINIR (cefdinir) submitted by Sandoz Inc.
-
FDA approval · 2020-01-28FDA Approved: AZITHROMYCIN — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals' original application for AZITHROMYCIN, granting a generic azithromycin product for the same indication…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and clavulanate potassium by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP [Phase 1, Phase 2]
Phase 1b/2a trial evaluating the safety and pharmacokinetics of Rhu-plasma Gelsolin in hospitalized adults with community-acquired pneumonia…
-
FDA approval · 2020-01-23FDA Approved: AZITHROMYCIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for azithromycin filed by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response [Phase 4]
Phase 4 clinical trial update evaluating the adequate duration of antibiotic treatment in community-acquired pneumonia with high-risk class …
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae [Phase 3]
Phase 3 trial evaluating daptomycin (Cidecin) in combination with ceftriaxone (Rocephin) for moderate to severe community-acquired bacterial…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia [Phase 3]
Phase 3 trial updating comparison of lefamulin to moxifloxacin for treatment of adults with community-acquired pneumonia completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia [Phase 3]
Phase 3 trial comparing lefamulin to moxifloxacin (± linezolid) for community-acquired pneumonia completed with results posted.
-
FDA label_change · 2019-09-20FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)
The FDA approved a supplemental application for ertapenem (ERTAPENEM SODIUM) submitted by ENDO USA, Inc.
-
FDA approval · 2019-04-19FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the Original Application for Amoxicillin and clavulanate potassium from Aurobindo Pharma Limited, a generic antibiotic product.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Santeon-CAP; Dexamethasone in Community-acquired Pneumonia [Phase 4]
Phase 4 trial update for dexamethasone in community-acquired pneumonia; study terminated.
-
FDA approval · 2019-03-19FDA Approved: ERTAPENEM — Original Application (Apotex Corp)
FDA approved Apotex Corp's original application for ertapenem sodium (ertapenem), a broad-spectrum carbapenem antibiotic, as a generic produ…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Increasing Community-acquired Pneumonia Protocol Adherence by Antibiotic Stewardship [NA]
This is a clinical trial status update from UMC Utrecht about a completed study evaluating whether antibiotic stewardship can improve protoc…
-
FDA approval · 2018-12-07FDA Approved: AZITHROMYCIN — Original Application (Lannett Company, Inc.)
FDA approves Lannett Company, Inc.'s original application for azithromycin (AZITHROMYCIN), a generic antibiotic.
-
FDA approval · 2018-10-02FDA Approved: NUZYRA — Original Application (Paratek Pharmaceuticals, Inc.)
FDA approved NUZYRA (omadacycline) from Paratek Pharmaceuticals as an original application. The approval covers acute bacterial skin and ski…
-
FDA approval · 2018-09-24FDA Approved: AZITHROMYCIN DIHYDRATE — Original Application (Precision Dose, Inc.)
FDA approved azithromycin dihydrate as a generic drug under Original Application by Precision Dose, Inc., expanding access to this antibioti…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia [Phase 4]
Phase 4 clinical study update for Anerning Particle in treating childhood community-acquired pneumonia.
-
FDA approval · 2018-08-02FDA Approved: TIGECYCLINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for tigecycline, authorizing a generic injectable antibiotic. It covers indic…
-
FDA approval · 2018-07-05FDA Approved: AZITHROMYCIN — Original Application (Aurobindo Pharma Limited)
FDA approved a generic azithromycin product under an Original ANDA for Aurobindo Pharma Limited.
-
FDA approval · 2018-06-25FDA Approved: ERTAPENEM — Original Application (Eugia US LLC)
The FDA approved an original application for ertapenem from Eugia US LLC, authorizing a generic version of the carbapenem antibiotic ertapen…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: Etiology of Community Acquired Pneumonia
Clinical trial update on the etiologies of community-acquired pneumonia, highlighting common bacterial pathogens such as Streptococcus pneum…